# Arcturus Therapeutics

RNA medicines company — LUNAR LNP platform enabling self-amplifying mRNA for vaccines (ARCT-154 approved in Japan) and liver-targeted RNA therapeutics.

Source: https://en.bioecon.ru/companies/arcturus-therapeutics/
Updated: 2026-06-19

- Country: United States
- Revenue: ~$20M
- Employees: 111 emp

## Technologies

- [mRNA platforms & LNP delivery](https://en.bioecon.ru/technology/mrna-platforms-lnp-delivery/)